Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Fish oil pills tested for lowering fat levels in overweight chileans

NCT ID NCT06538324

First seen Nov 01, 2025 · Last updated Jun 20, 2026 · Updated 34 times

Summary

This study tested whether low-dose omega-3 supplements (250 mg EPA per day) can improve cholesterol and inflammation in overweight or obese adults with high triglycerides. Forty participants in Chile took omega-3 or a placebo for six weeks each in a crossover design. The goal was to see if this simple dietary change could help control blood fat levels.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OVERWEIGHT are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Universidad San Sebastián

    Valdivia, Los Ríos Region, 5090000, Chile

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Omega-3 fatty acids (EPA) and high-oleic sunflower oil (HOSO) as a placebo

What this could lead to

If it works, this could point toward a simple dietary supplement to help manage high triglycerides in overweight individuals.

What could go wrong

This is a small, completed trial with only 40 participants, so results may not apply broadly. The omega-3 dose is low (250 mg EPA per day), which may not be enough to produce meaningful changes.

Conditions

The condition(s) this trial relates to.

hypertriglyceridemia Overweight

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.